Daily news email for June 18, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
D3 Pharma and Encap Drug Delivery Continue Partnership

Vetter Expands its Capacities and Services for Prefilled Syringes

GLYCOTOPE Moves PankoMab Towards Phase-II Clinical Development

Batavia Bioservices Opens Laboratory Facility in Greater Boston Area

BioGenes to Develop Specific HCP Assay for Boehringer Ingelheim

BioSpace
Mutations in JAK3 Gene Identified in Subtype of Lymphoma Provide Potential Drug Target, Study

Merck & Co., Inc. Loses Nasonex Patent Case

Genetic Markers Hope for New Brain Tumor Treatments, University of Nottingham Study

KV Pharmaceutical : FDA Issues New Update on Makena

Takeda Pharmaceutical Co. Ltd. to Stop Selling 13 Pfizer Inc. Drugs in Japan

BioSpace - Breaking News
Innate Announces Interim Results from Phase 2 Study of MIS416 in Secondary Progressive Multiple Sclerosis

Raptor Pharmaceutical Inc. Completes Enrollment in Phase 2/3 Clinical Trial of RP103 for the Potential Treatment of Huntington's Disease

Bristol-Myers Squibb Company Release: Six-Year Follow-Up Data for SPRYCEL (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib

Myriant Receives $25 Million Award Under USDA's Business and Industry (B&I) Loan Guarantee Program to Develop Bio-based Chemicals

Pharming Group Announces Presentation of New Ruconest(R) Clinical Data

Biotech News - Business Wire
Research and Markets: Global Flow Cytometry Market

Resumen: Oxford Immunotec eleva $28 millones para acelerar el aumento de las ventas comerciales

Samenvatting: Oxford Immunotec haalt $ 28 miljoen op

USDA Under Secretary Dr. Catherine Woteki Will Preview Leadership Summit Discussion at BIO Convention Buzz Center

Surveyed U.S. Oncologists Indicate They Would Prescribe Medivation/Astellas Pharma's Enzalutamide to 30 Percent of Their Second- and Third-Line Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients

Biotech News - PR Newswire
The UCB-Harvard Research Alliance Expands and Moves Forward

Vela Diagnostics entra en el mercado IVD

Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers

RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration

La European Hematology Association, l'American Society of Hematology et la European Cancer Patient Coalition lancent un appel à l'action international en vue de réduire les pénuries de médicaments

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
The July 2012 Issue of The Burrill Report

Mapping the Single Cell World

A Gentleman's D for Mitt

Startups raise $786 million in June's First Half

A Drug by Any Other Name

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
ALung Technologies Presents Positive Clinical Trial Results of the Hemolung Respiratory Assist System

The Gateway for Cancer Research Revamps Website to Help Patients Find Clinical Trials and Researchers Apply for Grants

Cardiovascular Systems Announces Five Abstract Presentations at Upcoming C3 Conference

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Pulse Oximetry Devices

KCI V.A.C.®FDA 510(k)

Clinical Trials - PR Newswire
Alma Lasers, Inc. Partners With Henry Schein Medical To Offer Latest Breakthrough In Nail Fungus Treatment

A Vascular Cause For Alzheimer's Is Revealed With The Backing Of Science Investor, Jeffrey Epstein

Israeli Medicine Breakthrough - For the First Time in the World and at the Initiative and Under the Leadership of Schneider Children's Specialists: The Artificial Pancreas MD-Logic was Tested in a Closed-Loop Trial Project in Patients' Homes at Nigh

DATATRAK Participates in DIA 2012 Annual Meeting

Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions

CNN Top Stories
Dismemberment suspect extradited

A new tablet from Microsoft

Egyptian military holds on to power

Tennis: Police probe bloody, angry kick

Google 3D maps coming soon

Contract Pharma
Bilcare GCS Names IVR/IWR Manager

CMC Biologics Passes PAI

Sentry BioPharma Adds Freezer

DSM Adds XD Client

Quintiles To Expand in China

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

FDA News - Business Wire
St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4

Cook Pharmica Receives Milestone FDA Approval For Commercial Manufacturing

LensAR Laser System Receives FDA Clearance for Anterior Capsulotomy and Laser Phacofragmentation in Cataract Surgery

KFx Medical Corporation Receives FDA 510 Clearance for smaller AppianFx® Tissue Fixation Anchor

Cannabis Science Appoints Former GlaxoSmithKline Global Director of HIV Research Dorothy Bray, Ph.D., to Scientific Advisory Board Focusing on CS-TATI-1 and Other Emerging Scientific Investigations

FDA Press Releases
Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena)

FDA approves new combination vaccine that protects children against two bacterial diseases

FDA urges that oysters, clams, mussels, and some types of scallops from Korea should be removed from the market

FDA approves Perjeta for type of late-stage breast cancer

U.S. Marshals seized misbranded drugs in Maine

FDA Vaccines, Blood and Biologics - What's New
Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

FierceBiotech
FDA worries about safety of Onyx's carfilzomib

FDA staffers cast doubts on Sanofi's pitch for key blood thinner

Ambrx inks $303M 'smart bomb' development pact with Merck

Infinity Pharma writes off lead drug after two more failed studies

Quintiles blueprints new Shanghai R&D center in expansion drive

FierceBiotech IT
Parexel trumpets unified tech for clinical trials software

Africa goes mobile to tackle drug safety woes

Harvard IDs key human-hosted bugs with computer systems

Third Rock fuels $41M launch of Bay Area biotech

Sequoia-backed startup enters race to make sense of the genome

FierceBiotech Research
Alzheimers and diabetes may be connected by a single gene

After death, some stem cells remain alive for days

Stem cell pioneer Shinya Yamanaka splits $1.5M Millennium Technology Prize

Enzyme revealed to be bacteria-killing maestro after all

New drug shows reduces post-stroke brain damage risk in mice

FiercePharma
FDA keeps door open to cheap versions of KV's Makena

Bigger Zytiga market a step closer with J&J's approval filings

Merck loses a patent ruling on blockbuster Nasonex

Should FDA's standards enforcement be blamed for drug shortages

Cipla chief aims for more cut-rate cancer drugs

FiercePharma Manufacturing
House report blames FDA actions for drug shortages

Filtrona completes acquisition of Lymtech Scientific

Cuts in drug manufacturing felt in U.K. industrial output

Smaller Indian drugmakers need support to improve GMPs

Loss for CMO Patheon smaller than expected

FierceVaccines
Vaccine, radiotherapy combo shows hints of prostate cancer efficacy

New HPV vax could treat cancer rather than prevent it

Chlamydia vaccine protects in animal studies

GeoVax: Meeting the HIV vaccine challenge

VaxInnate bird flu shot flies into Phase I

Health News - BizJournals.com
DBJ Tech Watch for Monday: Microsoft's tablet, Yahoo, Google, Ramtron

Millard Gates proposals to be made public

Central Florida Pulmonary Group expanding

Computerworld names 5 St. Louis firms in Best Places to Work in IT

Hamner Institute examining impact of liver drugs

Health News - CNBC
Alcohol abuse up after weight loss surgery: study

Infinity halts drug trials, shares fall

Merck in potential $300M research deal with Ambrx

Top court rules for Glaxo on overtime pay

FDA staff focus on Onyx cancer drug's side effects

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Oxford Immunotec Scores $28M to Ramp Up Commercialization of TB Test

Valeant Picks Up OraPharma for $312M to Expand into Oral Health

NCATS' Drug Repurposing Program Grows to Eight Pharmas, 58 Compounds

Third Rock Ventures Sets Up New Firm Global Blood Therapeutics with $40.7M

Upsher-Smith Takes Over Proximagen for CNS Disease Therapeutics

Marketwire - Pharma and Biotech
Addex to Present Phase 2a Dipraglurant Data at Movement Disorder Society's International Congress

Ohr Pharmaceutical to Present at the 2012 BIO International Convention

Media Advisory: MdBio Foundation to Preview Serious Game at BIO 2012 Convention

Computerworld Announces the Best Places to Work in Information Technology 2012 List

BIOLASE Waterlase iPlus(TM) All-Tissue Dental Laser System Wins Awards for High-Tech Innovation and Medical Design

MassBio News
MassBio Releases 2012 Complete Guide to the New England Life Sciences Industry at BIO

CB Richard Ellis N.E. Partners, LP Brings MassBio to Alexandria Real Estate Equities, Inc.'s 300 Technology Square

500 Massachusetts High School Students Spend a Day in Biotech Laboratories

Xenetic Biosciences moves drug development program to Massachusetts following Governor Patrick's Trade Mission to the UK

Breaking: MassBio Applauds House for Passage of PDUFA

Medical Pharma - PR Newswire
Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe

City of Denver and TZ Medical win a Gold Value Chain Award

Varian Medical Systems e Siemens Healthcare anunciam parceria global para melhorar serviços de radioterapia e radiocirurgia

Aperture Health, Inc. Executes LOI to Acquire Doctors on Call

Waters Breaks Ground on New Mass Spectrometry HQ in Wilmslow, UK

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
European agricultural policy goes down the tubers

The need for innovation in biomanufacturing

Should preclinical studies be registered

Reaching across the table

The gatekeepers of effectiveness

New York Times- Biotechnology
Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

New York Times- Pharmaceuticals
Texas Medicaid Overhaul Means Pain for Some Pharmacists

E-Mails Highlight Extent of Obama’s Deal With Industry on Health Care

When Children Take Drugs to Succeed

Experimental Surgery Targets Stubbornly High Blood Pressure

Genentech Wins Approval For New Breast Cancer Drug

OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India

Pharma News - Business Wire
BioAlliance Pharma renforce son équipe de développement avec larrivée du Dr Louis Kayitalire, au poste de Directeur Recherche et Développement

BioAlliance Pharma Reinforces Its Development Team with the Appointment of Louis Kayitalire, MD, as Head of Research and Development

Spectrum Pharmaceuticals Announces Outstanding ZEVALIN® Clinical Data In Aggressive Relapsed/Refractory Lymphoma; Presented at the 17th Congress of the European Hematology Association

Quintiles aumenta sus inversiones en China

Quintiles aumenta investimento na China

Pharma News - PharmiWeb
Wound Management Products Market Reaches $15.2 Billion by 2016, Driven by Rising Demand for Bandages and Dressings in Developing World

National Advocacy Organization for Addiction Treatment Elects Pavillon's CEO to its Board of Directors

ZzzQuil Relieves Occasional Sleeplessness

Research team says talking bollocks could save your life

New Data Show Majority of Patients with aHUS Experienced Systemic Multi-Organ Complications Prior to Treatment

Pharma News - PR Newswire
Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development

Getinge Online reçoit l'or au prix Value Chain Awards 2012 du magazine Connected World

China Botanic Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results

Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman

Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

PRWeb - Biotechnology
Axxiem Announces the Release of Axxivation Study Startup Module

ATCC Announces Agreement with Life Technologies Corporation to Sell...

Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012

Refractometer, New from Rudolph Research; The J47 Temperature...

Northeastern University Nanomanufacturing Center Director Ahmed...

PRWeb - Pharmaceuticals
Roll Handling with double clamping motorized attachment

Pharmica Consulting to Hold HIT Conference for the Pharmaceutical...

Medical Cannabis Patients Room Launches on Doobons.com

Popular Diabetes Drug Linked to Increased Risk of Bladder Cancer

Becker Law Office Launches New Website and Blog

Scientific American
Do Brain Scans of Comatose Patients Reveal a Conscious State

Fracking Can Cause Earthquakes, but So Can Oil and Gas Extraction

Triple-Bond: Boron Joins Elite Chemical Club

Earth Summit: A Report Card to Preview the Rio+20 Mega-Conference

Human-Eye Precursor Grown from Stem Cell

Sports - ESPN Basketball
Florida, Georgetown to play Nov. 9 on ship

Boston U to join Patriot League in 2013-14

Sources: UF, Georgetown to play Nov. 9 on ship

Sources: UF, Georgetown to play on naval ship

NCAA deregulates texts, calls to hoops recruits

Sports News - ESPN
Sandusky defense: Other coaches in showers

Sandusky prosecution rests after final witness

Rittenberg: The need for transparency

Meyer removes scholarships from two Buckeyes

No. 4 junior RB Green commits to Florida State

Xconomy Life Sciences
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore

Join Us for BIO Tweetchat at 8 am ET with Richard Pops

Merck Bets $15M on Ambrx's 'smart Bomb Antibodies

Three Good Things About BIO 2012, and Four Not-so-Good

XSITE 2012: Accelerating Innovation, Captured on Camera

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)